|
HS Code |
605242 |
| Product Name | HyaMatrix® 200 Crosslinked Sodium Hyaluronate |
| Main Ingredient | Crosslinked Sodium Hyaluronate |
| Hyaluronic Acid Origin | Biotechnological fermentation |
| Appearance | Transparent gel |
| Concentration | 20 mg/mL |
| Molecular Weight | High molecular weight |
| Crosslinking Agent | BDDE (1,4-Butanediol diglycidyl ether) |
| Sterility | Sterile |
| Application | Dermal filler, aesthetic procedures |
| Packaging | Pre-filled syringe |
| Storage Temperature | 2°C to 25°C |
| Endotoxin Level | <0.5 EU/mL |
| Biodegradability | Biodegradable |
| Ph Value | 7.0 ± 0.5 |
| Usage Area | Facial tissue augmentation |
As an accredited HyaMatrix® 200 Crosslinked Sodium Hyaluronate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for HyaMatrix® 200 Crosslinked Sodium Hyaluronate features a sterile 5g vial, labeled with product details and batch information. |
| Shipping | HyaMatrix® 200 Crosslinked Sodium Hyaluronate is securely shipped in airtight, tamper-evident containers to ensure product integrity. Packaging provides protection from moisture, light, and contaminants. Temperature-controlled shipping is available upon request to maintain stability. Each shipment includes detailed labeling and documentation in compliance with applicable chemical transport regulations. |
| Storage | **HyaMatrix® 200 Crosslinked Sodium Hyaluronate** should be stored in a cool, dry place, away from direct sunlight, heat, and moisture. Keep the container tightly sealed when not in use. Recommended storage temperature is between 2°C and 25°C. Avoid freezing. Ensure the product is protected from contamination and only handled with clean, dry equipment in a well-ventilated area. |
Applications of HyaMatrix® 200 Crosslinked Sodium Hyaluronate in Industrial ManufacturingAs the original manufacturer of HyaMatrix® 200 crosslinked sodium hyaluronate, we directly supply this specialized ingredient to downstream plants and OEMs operating in well-defined industrial segments. Below we summarize real-world application domains and offer scenario-specific details covering compliance, formulation levels, process integration, and end product types based on industrial production practice. 1. Injectable Dermal Filler Base for AestheticsThe primary industrial use of crosslinked sodium hyaluronate centers on its role as the structural gel matrix in injectable dermal fillers intended for professional aesthetic treatment. High molecular stability and controlled crosslinking enable manufacturers to develop advanced gel consistencies for precise volumizing, wrinkle correction, and facial contouring. The material’s rheological characteristics determine product viscosity, extrusion force, and tissue integration—all adapted according to label claims for fine-line, mid, or deep contouring applications. Each production batch must consistently meet rigorous purity, biocompatibility, and particle size requirements. Strict adherence to quality-by-design principles is practiced from the compounding stage to terminal sterilization and aseptic filling. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Viscosupplementation Formulation for Osteoarthritis ManagementBulk-crosslinked sodium hyaluronate serves a critical role in viscosupplementation products designed for intra-articular injection to restore synovial fluid viscoelasticity. Formulation technicalities revolve around molecular weight selection and crosslinking degree to replicate native joint-lubricating properties while extending intra-articular persistence post-injection. Strict input control and two-stage sterilization (sterile filtration plus terminal sterilization) are mandatory for downstream compliance. Processing lines maintain closed-system operation and low endotoxin environments as required for Class III device GMP. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Hydrogel-Base for Advanced Wound DressingsMedical dressing manufacturers select crosslinked sodium hyaluronate as a premium hydrogel-forming agent to create moist, non-adherent wound environments. Its three-dimensional network supports exudate absorption and active delivery of growth factors and antimicrobials. Downstream integration requires accurate hydration kinetics, sterilization resilience, and compatibility with processable sheet or film formats. Crosslink modification tailors the swelling ratio and flexibility to suit dressing types such as films, foams, and hydrogel sheets. Quality management hinges on bioburden control and validated sterilization cycles. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Ophthalmic Surgical Viscoelastic Devices (OVDs)Ophthalmic device manufacturers utilize highly purified, crosslinked sodium hyaluronate as the foundational component of viscoelastic solutions for cataract and other intraocular surgeries. Proprietary crosslinking profiles deliver the desired viscoelastic and cohesive-dispersive balance, facilitating anterior chamber maintenance, endothelial protection, and lens manipulation. Aseptic compounding under ISO 5 cleanroom conditions and sub-micron filtration assure compliance with sterile ophthalmic quality requirements. Each manufacturing run must undergo extensive rheological testing and endotoxin analysis. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Cosmetic Topical Gel and Mask BasesPersonal care manufacturers favor crosslinked sodium hyaluronate as a gel network builder in topical skincare formulations where extended moisturization and film formation are required. Its crosslinked structure delivers superior water retention and creates a non-oily, cushioning finish highly valued in high-end mask and leave-on gel products. Downstream plants require ingredient stability during heating and cooling cycles and compatibility with active dermocosmetic additives such as peptides, vitamins, and botanical extracts. Validated preservative systems and skin safety test documentation remain essential for global market access. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
6. Oral Care Moisturizing Gel FormulationsWithin the oral care domain, crosslinked sodium hyaluronate is incorporated into moisturizing gel products targeting dry mouth relief and post-dental procedure care. Its polyanionic structure forms a hydrating surface film on oral mucosa, aiding in symptomatic relief of xerostomia while also serving as an active delivery matrix for fluoride or antiseptic agents. Downstream processors must ensure low bioburden and validate ingredient compatibility with pharmaceutically active and flavor components. Consumer and dental-grade formulations follow specific dose and dispersibility guidance to optimize safety and performance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive HyaMatrix® 200 Crosslinked Sodium Hyaluronate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer deeply familiar with the daily hands-on work of producing hyaluronate polymers, new product development isn’t simply about launching “another” crosslinked hyaluronic acid gel to market. Every batch we scale from laboratory to production holds countless lessons—some learned the hard way on a pilot line. HyaMatrix® 200 is the result of persistent refinement, targeted raw material selection, and consistent dialogue with clinical and cosmeceutical formulators who demand stable rheology and reliable integration with their technologies. Our batch-to-batch control matters just as much as our understanding of how crosslinking chemistry dictates the real-world performance in topical gels, wound care matrices, or injectable viscoelastic materials.
We designed the HyaMatrix® 200 crosslinked sodium hyaluronate as a direct response to market requests for a higher-purity, precisely crosslinked grade with easy dispersion and stable viscosity over time. Laboratory teams often approach us asking why some crosslinked hyaluronates clump, degrade, or change in texture during months of storage, or under autoclaving. Years producing unmodified and modified hyaluronans taught us which crosslinkers, reaction controls, and purification steps cause lingering odor, too much network density, or foreign particulate contamination in finished gels. Many “off-the-shelf” options claim purity, but without in-house gel-permeation data and real-time QC during the reaction, these inconsistencies persist and show up down the line as customer complaints or product recalls. We approach every production lot of HyaMatrix® 200 as if we’re making it for our own clients’ flagship brand, measuring success by a record of stable outcomes and real feedback from the field.
With HyaMatrix® 200, our model designation reflects an optimized crosslinked hyaluronate ideal for higher-volume aesthetic, wound care, and medical device formulations. Each lot typically presents with a particle range targeting applications that need controllable swelling and predictable gel formation, instead of random lumping or sedimentation. The dry polymer holds a white to off-white appearance, free from specks and insolubles, which comes from careful sequential filtration and wash steps after crosslinking. We use only non-animal, fermentation-derived sodium hyaluronate as the starting material, cutting out the risk of zoonotic contaminants that still persist in some animal-sourced brands on the world market. This microbial-grade origin means the risk of DNA, endotoxin, or protein byproducts is kept well below what global cosmetic and injectable standards demand.
The crosslinking process itself drives the unique properties of HyaMatrix® 200. We worked for years to build a crosslinker delivery and wash-out protocol that gives a wide network, with a moderate crosslink density. Instead of the brittle or too-dense gels sometimes seen in competitors’ products—especially those using excess crosslinker for yield—our material produces smooth, clear hydrogels with a “bounce” during application and less risk of flaky by-product precipitation during storage. Controlled reaction kinetics ensure the molecular weight distribution stays tight, maximizing water uptake without gummy, sticky masses that resist proper blending or extrusion.
Specifications for HyaMatrix® 200 are not just numbers to quote. Each production run undergoes strict counts for residual crosslinkers, low-molecular fraction, and bacterial endotoxins. This goes further than “pass/fail” testing; we know firsthand that even subvisible fine particulates can lead to visible haze later in a product’s shelf life. Consistent particle size is not only about aesthetics. It relates to filtration integrity during final formulation and prevents filter clogging in lines or syringes, reducing downtime on filling equipment and hand labor for operators. These minute details matter to us, as cost and labor savings for bulk buyers add up over years.
Research and collaboration with product developers shape our understanding of how crosslinked sodium hyaluronate performs beyond the lab bench. Formulators for dermal fillers and wound matrices use HyaMatrix® 200 because of its stable hydration properties and ease of swelling to produce thick, clear gels. Unlike some lower-grade materials prone to syneresis or rapid degradation under mechanical agitation, our material resists breakdown and handles high-shear mixing—a trait verified by our partners in medical device assembly and automated gel blending.
The end-use cases stretch from bioactive wound dressings—where high water content and gradual cellular infiltration are important—to topical beauty blends that need a light, smooth touch with sustained film formation on skin. In clinical environments, product engineers reported HyaMatrix® 200 hydrogels maintained transparency and consistent texture in storage studies up to 24 months, without yellowing or loss of viscosity. These properties directly result from starting with high molecular weight sodium hyaluronate, targeted crosslink ratios, and thorough wash steps. In the cosmeceutical realm, the product blends cleanly with peptides, vitamins, and plant extracts, with pH stability supporting compatibility across a range of actives.
More than once, clinical skin specialists shared feedback that competing products often left behind rough, crumbly residues or formed “beads” in finished gels after a season on the shelf. We rarely encounter such returns with HyaMatrix® 200, as repeatable texture and resilience to freeze-thaw cycles have been central to our process optimization. Clinics in humid climates also report fewer issues with mold growth or souring, credited to our extensive endotoxin and microbial quality controls.
Competition in the market usually claims incremental advances in purity or ease of mixing, but as actual manufacturers, we look at differences on a more practical level. For example, some rival crosslinked hyaluronic acids include excessive crosslinking, which leads to brittle, crumbly textures that break apart on pumping or manual application. Other suppliers cut corners with incomplete purification, leading to yellowing and unstable gels six to twelve months after manufacturing. Our approach rejects these shortcuts.
A notable difference lies in process transparency. Our facility allows partners to trace each batch lot from fermentation tank to crosslinking to packaging, with retained samples for every shipment. We regularly audit our own upstream suppliers, ensuring no contamination or premature oxidation alters product performance. In cases where customers require custom particle sizing or modification in swelling rates, we adapt our process flow and document the changes, allowing side-by-side evaluation with prior lots. This level of traceable manufacturing remains rare among private-label or bulk traders who lack internal chemistry or QC staff.
Many crosslinked hyaluronates currently available show significant batch-to-batch variability in gel hardness, which comes from inconsistent crosslinking and substandard washing—sometimes to maximize throughput at the expense of purity. In contrast, HyaMatrix® 200’s tightly managed process ensures water-soluble residues and unreacted crosslinker are thoroughly removed, minimizing endotoxin levels and reducing the risk of delayed hypersensitivity reactions in topical or injectable applications. This extra investment in purification doesn’t just make the material safer; it limits batch rejection and costly rework for finished product manufacturers, diagnostics developers, and device firms.
Field experience quickly teaches that not all hyaluronates behave equally during actual production. Some crosslinked grades resist uniform dissolution in aqueous or buffered solutions, leading to “fish eyes,” extruder jams, or wasted material during scale-up. Our in-house applications lab works alongside clients to solve these challenges, reducing rework and waste by providing materials that disperse smoothly under typical agitator or recirculation conditions in bulk reactors. The finished HyaMatrix® 200 powder wets out efficiently, minimizing incomplete hydration and lumps. The subtle details here—from post-crosslink drying to proprietary milling steps—determine whether the user’s day on the production floor runs smoothly or ends with an unscheduled equipment teardown.
Customer conversations also guide improvements. One issue raised repeatedly involves the gel’s color shift under varying warehouse temperatures or after long transit. Our multi-stage vacuum drying helps prevent oxidized byproducts, resulting in stable color and a longer shelf life even in hot, humid climates. The finished product packs and ships in light-blocking, moisture-sealed packaging to prevent off-flavors and premature yellowing—a small detail, but one supported by customer retention rates and fewer returned shipments for replacement.
As a manufacturer living with the realities of batch-to-batch consistency, downtime, and process troubleshooting, we view R&D not through marketing promises but as a direct investment in smoother scale-up and fewer recall risks. Every formulation adjustment, from a new crosslinker to a minor tweak in purification, passes internal and external stress tests for yield and downstream performance. This commitment affects everything from small-batch specialty orders to truckloads destined for multinational OEMs. On the floor, our engineers focus on small parameters like jacketed reactor temperature rates or mixing speeds—details often overlooked until a batch produces abnormal viscosity or gels out too soon.
Upgrading reactor controls and filtration lines, we’ve reduced foreign particulate incidents below regulatory thresholds set by Europe and North America. Our operators run parallel real-time QC during crosslinking—not merely endpoint checks—so issue identification and correction occurs before full batch investment. Many competitors still depend on post-hoc analysis, only finding faults after a metric ton is committed to packaging. Such a mistake can take weeks to recover from in global supply chains, stranding clients and damaging brands.
Clients benefit from our in-house analytics. From real-time GPC to NMR screening for crosslinker residues, our own lab benches every shipment against both our specs and evolving global norms. Frequent engagement with regulatory teams assures lot documentation and compliance keep pace with changing requirements in medtech and cosmeceuticals. Third-party audits verify our control of potential allergens and aggressive crosslinker residues, critical points in therapeutic and topical applications.
We consider ourselves more partners than vendors for formulators and device engineers. Early in our relationship with new development teams, shared data, protocols, and field testing highlight potential tweaks—be it slightly altered swelling rates or adaptation to a unique pH environment. Our production teams remain accessible, supporting pilot and scale-up batches and troubleshooting any outlier phenomena that might arise in downstream processing. Building long-term trust hinges upon more than low unit costs; it depends on standing behind product consistency, delivery timelines, and open exchange over real-world usage outcomes.
Our manufacturing philosophy is rooted in the belief that every lot impacts a wider system: the drug or cosmeceutical company developing safer products, the clinicians seeking fewer adverse reactions, the consumer relying on purity they never see but always expect. HyaMatrix® 200 grows with each production and R&D cycle, reflecting the feedback and needs of those directly using the material day in and day out.
Manufacturing crosslinked sodium hyaluronate like HyaMatrix® 200 is a process of continual learning and adaptation. Experience—earned during difficult production days, hands-on formulation trials, and listening sessions with end users—drives ongoing improvements. Every modification to our process must yield rewards in day-to-day use, not just in laboratory tests, but in real production, packaging, and downstream integration. Through direct engagement for quality control, process adjustment, and personalized support, our company strives to provide not only a consistent, reliable product, but also a practical partnership to help industry clients focus on innovation rather than troubleshooting raw material issues. HyaMatrix® 200 embodies the value that hard-won manufacturing experience brings to demanding clinical, cosmetic, and medical applications.
